May 12, 2023
Scientific cooperation between the U.S. and the Republic of South Africa was initiated in 1995 and has grown in recent years. Recognizing that enhanced cooperative biomedical research would be of mutual benefit to the U.S. and South Africa, the NIH Director and the President of the South African Medical Research Council (MRC) signed a Memorandum of Understanding (MOU) in January 2013 to develop the U.S.-South Africa Program for Collaborative Biomedical Research. The first phase of this program included awards made in response to RFA-AI-14-009, RFA-AI-14-010, RFA-AI-14-018, RFA-AI-16-039, RFA-AI-16-040, RFA-AI-16-082, and RFA-AI-16-083. A working group, made up of members from both the NIH and MRC, developed strategic plans for continued collaboration. Both the NIH and MRC have allocated resources to support the second phase of this program.
Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogeneous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. There are many benefits that flow from a diverse NIH-supported scientific workforce, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of research, advancing the likelihood that underserved or health disparity populations participate in, and benefit from health research, and enhancing public trust. In spite of tremendous advancements in scientific research, information, training, and research opportunities are not equally available to all. FIC encourages institutions to diversify their trainee populations to enhance the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral and social sciences. such as individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds (See NOT-OD-20-031).
Establishing and maintaining scientific environments that are inclusive and can cultivate and benefit from a full range of talents is not only essential for the quality and impact of science, but it is also a matter of good stewardship of federal funds to ensure that the most talented researchers are recruited, supported, and advanced to become competitive research investigators.
This funding opportunity is part of Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research. An overarching goal of this bilateral program is to foster diversity, equity, and inclusion in the biomedical research workforce. For purposes of this NOSI, we encourage applicants to recruit prospective scientists from diverse backgrounds, including those from groups underrepresented in the biomedical sciences and scientists from historically disadvantaged institutions (HDIs) in South Africa.
Fogarty International Center (FIC) is inviting applications to expand existing FIC D43 and U2R awards in South Africa to provide career enhancement opportunities to build research skills and experience of scientists from diverse backgrounds, including those from underrepresented groups in biomedical research. These opportunities are intended to target under-resourced institutions and individuals with a demonstrated commitment to biomedical research. The goal is to include scientists from South African HDIs/South African Universities of Technology with limited resources or experience.
The objective of this initiative is to promote diversity, equity, and inclusion in FIC research training programs (D43, U2R). Applicants should propose to provide a foundation in research design, methods, and analytic techniques appropriate for the proposed research area in an inclusive research environment that welcomes contributions from trainees of all backgrounds. Activities can include mentored research, practicums, workshops, short courses, or other activities as appropriate, and may contribute to Masters’ level training.
South African programs that do not meet the criteria for this NOSI may still apply to the companion funding opportunity (see NOT-TW-23-006). Once we fill all awards from the joint MRC SA-NIH program applying for this opportunity, supplements may still be awarded from the companion NOSI. Duplicate applications to both Notices are not necessary and are not allowed.
Individuals and institutions eligible to apply:
The following universities have been designated by the MRC as HDIs:
South African Universities of Technology:
The research strategy section of the proposal may be no more than six pages (exclusive of the Specific Aims page and biosketches) and should include the following parts:
Administrative review will be conducted by the FIC consistent with applicable law.
Number, duration, and budget of awards:
Budgets up to $150,000 total costs (direct plus F&A of 8%) for one year are allowed, with budget justification.
Funds should be used consistent with the restrictions on the parent award and may include, among other costs: stipend support for trainees, salary support for key personnel contributing to the program, consultants, participant(s) costs, costs for materials and internet connectivity, facility costs to hold meetings, and travel for faculty and for participant(s).
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
Please direct all inquiries to:
National Institutes of Health
Fogarty International Center
South African Medical Research Council
Telephone: +27 21 9380653
Christopher Barnhart, PhD
Sexual & Gender Minority Research Office (SGMRO)